Health Canada

The Canadian Cannabis Survey (CCS) 2024, released by Health Canada on December 6, offers fresh insights into public attitudes, behaviors and trends surrounding cannabis consumption in Canada. The survey, conducted between April 4 and July 2, 2024, reveals significant changes in how Canadians engage...

Health Canada is set to reduce spending on its cannabis program by CA$20.5 million ($14.6 million) over the next three years. This move is part of the federal government’s “Refocusing Government Spending” initiative aimed at saving CA$15.8 billion over five years. Canada's...

Neuralink, the brain implant company founded by Elon Musk, has received approval from Health Canada to launch its first clinical trial in the country. What Happened: On Wednesday, University Health Network announced that the trial would occur at Toronto Western Hospital. UHN CEO Kevin Smith said...

Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants conducted by consumer insights company Antenna, reported Cannabiz. The Medigrowth-commissioned study revealed that 22% of respondents either contemplated or...

Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis, simultaneously emphasizing the country's existing restrictions on the use of other...

Canada’s medical cannabis landscape is facing a profound transformation. Since the legalization of recreational marijuana in 2018, there has been a steep decline in both patient registrations and spending. The challenge now lies in deciphering the reasons and navigating future implications....

Health Canada has instructed five licensed cannabis companies to halt the sale of specific ingestible marijuana products categorized as "ingestible extracts" instead of edibles. In Canada, edibles face a maximum THC limit of 10 milligrams per package, while extracts or...

In a challenge to Health Canada's recent decision to restrict the sale of cannabis extracts that go beyond the federal 10mg THC packaging limit, cannabis producer Organigram Holdings Inc. (NASDAQ: OGI) filed for a judicial review. Organigram is one of several companies that...

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental health conditions and how clinical data is crucial to pulling institutional...

A Contract Research Organization (CRO) and a wholly-owned subsidiary of Wellbeing Digital Sciences Inc. (OTC: KONEF), KGK Science’s application for a Controlled Drugs And Substances (CDS) dealers license with Health Canada has been approved to proceed with the buildout of a level 5 security...

Licensed psychedelic drugs producer Optimi Health Corp. (OTCQX: OPTHF) submitted a Health Canada clinical trial application (CTA) for a Phase 1 study that will assess the safety of combining its natural psilocybin standardized extract with its proprietary MDMA drug candidate in healthy therapists....

In Canada, a Federal Court ruled that data on the locations of large-scale medical cannabis growers will be protected from disclosure, reported The Globe And Mail. What Happened In 2017, The Globe submitted a request to Health Canada seeking access to a list of addresses of individuals...

Australian Health Authority To Allow Psilocybin And MDMA-Assisted Therapy For Depression, PTSD Beginning on July 1, 2023, medicines containing psilocybin and MDMA can be prescribed by specifically authorized psychiatrists to treat certain mental health conditions, such as ...

Health Canada recently required several cannabis companies to stop selling certain products on the grounds that they were incorrectly labeled as extracts rather than edibles. And now, reports MJBizDaily, Health Canada is looking into cannabis companies that allegedly misclassify...

Canadian cannabis companies have been required to stop selling certain ingestible cannabis products, which could cost the industry millions.  What Happened Health Canada, the Canadian federal agency for Public Health, deemed that certain products sold by some cannabis companies have...